| pubmed-article:12441803 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0033607 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:12441803 | lifeskim:mentions | umls-concept:C0439230 | lld:lifeskim |
| pubmed-article:12441803 | pubmed:dateCreated | 2002-11-20 | lld:pubmed |
| pubmed-article:12441803 | pubmed:abstractText | A randomized study to evaluate the usefulness of protease inhibitor (PI) therapeutic drug monitoring (TDM) in antiretroviral-experienced HIV-infected patients. | lld:pubmed |
| pubmed-article:12441803 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12441803 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12441803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12441803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12441803 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12441803 | pubmed:author | pubmed-author:DurantJacques... | lld:pubmed |
| pubmed-article:12441803 | pubmed:author | pubmed-author:ClevenberghPh... | lld:pubmed |
| pubmed-article:12441803 | pubmed:author | pubmed-author:DellamonicaPi... | lld:pubmed |
| pubmed-article:12441803 | pubmed:author | pubmed-author:GarraffoRodol... | lld:pubmed |
| pubmed-article:12441803 | pubmed:copyrightInfo | Copyright 2002 Lippincott Williams & Wilkins | lld:pubmed |
| pubmed-article:12441803 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12441803 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12441803 | pubmed:pagination | 2311-5 | lld:pubmed |
| pubmed-article:12441803 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12441803 | pubmed:articleTitle | PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results. | lld:pubmed |
| pubmed-article:12441803 | pubmed:affiliation | Infectious Diseases Department, CHU Nice, Nice, France. clevenberghph@hotmail.com | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12441803 | lld:pubmed |
